Type I Diabetes Clinical Trial
Official title:
Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)
Background:
- Type 1 diabetes (T1D) is a common chronic disease in children, occurring in
approximately 1 of every 400 to 600 children. Children with T1D are unable to produce
insulin, a hormone that allows the body to use glucose from food. Children with T1D
manage their diabetes by taking insulin, monitoring their blood glucose levels, and
watching their diet, including carbohydrates.
- Carbohydrates come from many different kinds of food, and recent research has shown that
different foods have a different effect on the level of glucose in the blood. In
general, whole, unprocessed foods (e.g., fruits, vegetables, whole grains, legumes) have
a lower glycemic index (GI), which means that they cause smaller, more sustained blood
sugar levels. Additionally, these foods are rich in nutrients. Nutrient-poor
carbohydrates come from foods made with refined grains and sugars, such as breads,
crackers, and breakfast cereals; they general cause a more rapid increases in blood
sugar (i.e., a high GI). Lower GI diets may help people with T1D manage their blood
glucose levels more easily.
Objectives:
- To determine the utility of a whole foods, low GI diet in the management of T1D.
- To determine the utility of a behavioral intervention to promote healthful family
dietary behaviors, including eating more fruits, vegetables, whole grains, and legumes,
and fewer refined carbohydrates.
- To determine how the dietary intervention affects quality of life, satisfaction with the
diet, and risk for problem eating behaviors.
Eligibility:
- Children 8 to 16 years of age who have been diagnosed with T1D for more than 12 months, and
who use insulin injections to maintain normal blood glucose levels.
Design:
- Families will be divided into two groups: an intervention group that will participate in
intensive dietary intervention and continuous glucose monitoring (CGM) and a control
group that will not have the dietary intervention but will have CGM and scheduled
contacts with study staff.
- Intervention group families will have 11 family-based and 2 group-based sessions
consisting of behavioral techniques and educational content about eating nutrient-dense,
low GI foods. CGM results will give families feedback about how their diet affects blood
glucose levels. At least one parent and the child with T1D will participate in the
intervention.
- Intervention topics will consist of goal setting, behavior self-monitoring, educational
information, and problem solving, among others. Parents and children will record the
foods they eat.
- Control group families will participate in 11 family-based sessions consisting of CGM
feedback.
- Assessments will be conducted at 6, 12, and 18 months, and medical record information,
including blood and urine testing, will be obtained at each routine clinic visit.
This protocol describes a randomized controlled trial to promote consumption of carbohydrates from nutrient-dense whole foods among children and adolescents with type 1 diabetes and to determine the efficacy of such dietary changes in improving glycemic control and other diabetes-related health outcomes. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05160142 -
Diabetes Inspired Culinary Education
|
Early Phase 1 | |
Withdrawn |
NCT05035368 -
Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT01928329 -
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
|
Phase 2 | |
Completed |
NCT02127762 -
The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy
|
N/A | |
Completed |
NCT04279613 -
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041
|
Phase 1 | |
Not yet recruiting |
NCT02117518 -
Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients
|
N/A | |
Withdrawn |
NCT01477476 -
Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes
|
Phase 2 | |
Terminated |
NCT01308437 -
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
|
Phase 3 | |
Terminated |
NCT01652911 -
A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT06242548 -
How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at Altitude
|
N/A | |
Completed |
NCT00351650 -
Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan
|
N/A | |
Withdrawn |
NCT00361608 -
Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device
|
N/A | |
Terminated |
NCT03653533 -
Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump
|
N/A | |
Completed |
NCT00340639 -
Management of Type 1 Diabetes Among Adolescents
|
N/A | |
Completed |
NCT02634216 -
Effects of Capros in Patients With Type-1 Diabetes
|
N/A | |
Completed |
NCT02002130 -
The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
|
Phase 1 | |
Withdrawn |
NCT01623388 -
Epigenetic Modifications of Diabetes Mellitus Type I
|
N/A | |
Completed |
NCT02612493 -
Obesity and Metabolic Surgery in Patients With Type I Diabetes
|
N/A | |
Completed |
NCT01843114 -
Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects
|
N/A | |
Withdrawn |
NCT01398670 -
Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics
|
Phase 3 |